A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel
Abroad (travel likely)Recruiting
Conditions
Cerebral Adrenoleukodystrophy (CALD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Boston Children's Hospital, Boston, Massachusetts, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
UT Southwestern Medical Center, Dallas, Texas, United States
Study leads
Kiran Bhirangi, MD
Study Director
bluebird bio, Inc.